Na Lv

1098 Xueyuan Ave
Shenzhen, 518060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 11, 2021

Facile generation of bridged medium-sized polycyclic systems by rhodium-catalysed intramolecular (3+2) dipolar cycloadditions.

Facile generation of bridged medium-sized polycyclic systems by rhodium-catalysed intramolecular (3+2) dipolar cycloadditions.

Journal: Nature communications

Published: April 21, 2021

Unveiling structural, electronic properties and chemical bonding of (VH2)n (n=10-30) nanoclusters: DFT investigation.

Unveiling structural, electronic properties and chemical bonding of (VH2)n (n=10-30) nanoclusters: DFT investigation.

Journal: Journal of molecular graphics & modelling

Published: December 27, 2020

Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.

Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.

Journal: Experimental hematology & oncology

Published: October 28, 2020

Loss of X chromosome predicts favorable prognosis in female patients with t(8;21) acute myeloid leukemia.

Loss of X chromosome predicts favorable prognosis in female patients with t(8;21) acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: January 10, 2020

Loss of the Y chromosome predicts a high relapse risk in younger adult male patients with t(8;21) acute myeloid leukemia on high-dose cytarabine consolidation therapy: a retrospective multicenter study.

Loss of the Y chromosome predicts a high relapse risk in younger adult male patients with t(8;21) acute myeloid leukemia on high-dose cytarabine consolidation therapy: a retrospective multicenter study.

Journal: Leukemia & lymphoma

Published: November 15, 2019

Acute myeloid leukemia immune escape by epigenetic CD48 silencing.

Acute myeloid leukemia immune escape by epigenetic CD48 silencing.

Journal: Clinical science (London, England : 1979)

Published: November 13, 2019

Single‑cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction.

Single‑cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction.

Journal: Oncology reports

Published: September 11, 2019

Chidamide inhibits t(8;21) AML cell proliferation and AMK1/ETO and C-KIT expression by inhibiting ERK1/2 signaling pathway.

Chidamide inhibits t(8;21) AML cell proliferation and AMK1/ETO and C-KIT expression by inhibiting ERK1/2 signaling pathway.

Journal: Translational cancer research

Published: May 30, 2019

Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen.

Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen.

Journal: International journal of cancer

Published: February 21, 2019

The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter.

The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter.

Journal: The FEBS journal

Published: July 02, 2018

Investigation of PRAM1 Expression Features and Their Clinical Significance in AML via Gene Expression Microarray Database

Investigation of PRAM1 Expression Features and Their Clinical Significance in AML via Gene Expression Microarray Database

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 19, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026